Characteristics of relapsing remitting multiple sclerosis patients as possible indicators of response to interferon beta-1b (IFN BETA-1b) treatment

被引：0
|
作者：
Duquette, P
HoudeSauve, M
Bedell, L
机构：
来源：
NEUROLOGY | 1997年 / 48卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：3068 / 3068
页数：1
相关论文
共 50 条
  • [1] Treatment of multiple sclerosis with interferon beta-1b
    AbdulAhad, A
    Shah, S
    Galazka, A
    [J]. NEUROLOGY, 1997, 49 (02) : 641 - 641
  • [2] Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
    Jankovic, Slobodan M.
    [J]. JOURNAL OF INFLAMMATION RESEARCH, 2010, 3 : 25 - 31
  • [3] Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
    Paolicelli, Damiano
    Direnzo, Vita
    Trojano, Maria
    [J]. BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 369 - 376
  • [4] Neutralizing antibodies and the efficacy of interferon beta-1b in relapsing-remitting multiple sclerosis
    Petkau, J
    White, R
    [J]. MULTIPLE SCLEROSIS, 1997, 3 (06): : 402 - 402
  • [5] Interferon beta-1b treatment in patients with relapsing-remitting multiple sclerosis under a standardized protocol in Spain
    Arbizu, T
    Alvarez-Cermeño, JC
    Decap, G
    Fernández, O
    Uría, DF
    Merino, AG
    Izquierdo, G
    Montalbán, X
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2000, 102 (04): : 209 - 217
  • [6] Neutralizing Antibodies during Treatment with Interferon Beta-1b in 1745 Patients with Relapsing-Remitting Multiple Sclerosis
    Goodin, Douglas
    O'Connor, Paul
    Hartung, Hans P.
    Kappos, Ludwig
    Arnason, Barry
    Comi, Giancarlo
    Cook, Stuart
    Filippi, Massimo
    Jeffery, Douglas
    Bogumil, Timon
    Sandbrink, Rupert
    Beckmann, Karola
    Boateng, Francis
    Pohl, Christoph
    [J]. NEUROLOGY, 2009, 72 (11) : A317 - A318
  • [7] COST-UTILITY ANA LYSIS OF INTRAMUSCULAR INTERFERON BETA-1B VERSUS SUBCUTANEOUS INTERFERON BETA-1B AND BETA-1A IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN COLOMBIA
    Ordonez, J.
    Delgado, A.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A63 - A63
  • [8] Further study on the specificity and incidence of neutralizing antibodies to interferon (IFN) in relapsing remitting multiple sclerosis patients treated with IFN beta-1a or IFN beta-1b
    Antonelli, G
    Simeoni, E
    Bagnato, F
    Pozzilli, C
    Turriziani, O
    Tesoro, R
    Di Marco, P
    Gasperini, C
    Fieschi, C
    Dianzani, F
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 168 (02) : 131 - 136
  • [9] Interferon beta-1b in relapsing-remitting multiple sclerosis: the effect of disease duration on treatment efficacy
    Rusek, S.
    Hozejowski, R.
    Tutaj, A.
    Kozlowska-Boszko, B.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 257 - 257
  • [10] Multiple sclerosis: Treatment with recombinant interferon beta-1b
    Huber, S
    Spycher, M
    LechnerScott, J
    Bellaiche, Y
    Steck, AJ
    Kappos, L
    [J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1996, 126 (35) : 1475 - 1481
12345